New Digital Health Technology to Help cancer Patients Wins Top Innovation Prize

A start-up established by medical scientists that develops mobile apps for cancer patients has taken first place in the inaugural Digital Health Masterclass Challenge hosted by Janssen Healthcare Innovation and Johnson & Johnson Innovation in London. The cutting-edge technology designed to personalise medical support for patients with cancer and improve the patient-doctor relationship highlights how digital health businesses across Europe are fast securing their position as key players in today's health ecosystem. Pitching to a select panel of judges against 19 fellow digital health start-ups at the Masterclass Challenge, Px Healthcare, an Amsterdam-based company, secured first place and the top prize of €30,000 to help grow their offering.

Taking second place and a prize of €15,000 was DrEd, a new breed of online doctor that provides remote medical consultations for a range of conditions including sexual health testing and travel health. Currently operating out of the UK, Germany, Austria and Switzerland, the online doctor platform offers video consultations and can also issue electronic prescriptions. Onco Drug Personalised Med (ODPM), a French-based start-up that develops digital solutions for personalised treatment for cancer patients, secured third place and a prize of €5,000. ODPM has developed web-based calculators to determine the risk of toxicity in patients to be treated with fluoropyrimidines and provides dose adaptation to improve quality of life during chemotherapy and reduce hospital costs.

Marco Mohwinckel, Partner, Janssen Healthcare Innovation, said: "We want to congratulate not just the winners of this award, but all 20 companies who were selected to take part in the Digital Health Masterclass Challenge. The judging panel was hugely impressed by the digital healthcare solutions demonstrated by all the participating companies. Reaching a final decision was not easy."

Twenty leading digital health start-ups from nine European countries were selected to participate in the Masterclass from over 100 applicants. Each of the start-ups has developed an innovative product, service or proposition using the latest technologies such as mobile apps, cloud-based solutions and wireless sensing technologies to addresses a particular healthcare need. Following selection, the companies participated in three sessions in Berlin, Barcelona and London, where they were exposed to a growth-focused curriculum, expert advice, and close interaction with customers, international influencers, executives from the Johnson & Johnson Family of Companies and investors.

Marco Mohwinckel continued: "I'm proud to say we’ve left a mark and it's been rewarding to see friendships form and ideas grow. I’m sure many of these digital health start-ups will now be accelerating their ideas as a result of the Masterclass."

One of the main objectives of the Masterclass was to provide practical guidance and support to entrepreneurs at a critical stage in their growth, led by experts from across the Johnson & Johnson Family of Companies, including the dedicated entrepreneurial teams at Janssen Healthcare Innovation, Johnson & Johnson Innovation Centre London, and Johnson & Johnson Consumer Health.

Patrick Verheyen, Head of Johnson & Johnson Innovation, London, said: "Connecting innovators with the right resources has the potential to accelerate new health solutions and improve the lives of patients. By pooling the expertise across the Johnson & Johnson Family of Companies, we can be a catalyst to these rising stars of digital health and others in the innovation ecosystem."

The Masterclass culminated with the Challenge Awards and networking event in London on 20 November, attracting over 100 members of the European digital health community, including entrepreneurs and investors. The event showcased the diversity of innovative digital health solutions on the horizon in Europe to help tackle some of the most pressing health challenges facing patients, their families and healthcare professionals.

About the Digital Health Masterclass participating companies
The digital health companies who participated in the Digital Health Masterclass included: BrainControl, DocCom, Doctor Kinetic, Dr Ed, Educamigos, Smartbrain, Exco InTouch, GroupNos Technologies, Mint Solutions, Onco Drug Personalized Medicine, Optimal Medicine, Px HealthCare, Shimmer, Silver Cloud, Skin Analytics, Soma Analytics, SwiftQueue, Take the Wind, Vivago, and Wireless Sensor Networks.

About Janssen Healthcare Innovation
Janssen Healthcare Innovation is an entrepreneurial team within Janssen Research & Development, LLC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The Janssen Healthcare Innovation team is developing transformative integrated care businesses and building enabling technologies that harness the broad and differentiated capabilities of Johnson & Johnson to address the fundamental challenges of healthcare delivery.

About Johnson & Johnson Innovation
The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients.

About Johnson & Johnson Consumer Health
Caring for the world, one person at a time ... inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 129,000 employees at more than 250 Johnson & Johnson operating companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

Most Popular Now

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

AI Detects Early Signs of Osteoporosis f…

Investigators have developed an artificial intelligence-assisted diagnostic system that can estimate bone mineral density in both the lumbar spine and the femur of the upper leg, based on X-ray images...

AI could Help Pathologists Match Cancer …

A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and collaborators, suggests that artificial intelligence (AI) could significantly improve how...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

AI Accurately Classifies Pancreatic Cyst…

Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to extract and analyze specific data points from the Magnetic Resonance Imaging...

Free AI Tools can Help Doctors Read Medi…

A new study from the University of Colorado Anschutz Medical Campus shows that free, open-source artificial intelligence (AI) tools can help doctors report medical scans just as well as more...

Autonomous AI Agents in Healthcare

The use of large language models (LLMs) and other forms of generative AI (GenAI) in healthcare has surged in recent years, and many of these technologies are already applied in...

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...